| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
1,038,981 |
$3,428,637 |
$3.30 |
09 Apr 2025 |
Direct |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
250,000 |
$825,000 |
$3.30 |
09 Apr 2025 |
By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
250,000 |
$825,000 |
$3.30 |
09 Apr 2025 |
By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
95,001 |
$313,503 |
$3.30 |
09 Apr 2025 |
By Fried-Travis Revocable Trust U/A Dated 06/02/1999 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
12,746 |
$42,062 |
$3.30 |
09 Apr 2025 |
Indirect |
| ChromaDex Corp. |
Chief Executive Officer, Director |
Performance Stock Unit |
1,518,600 |
|
|
25 Feb 2025 |
Direct |
| ChromaDex Corp. |
Chief Executive Officer, Director |
Employee Stock Options (right to buy) |
492,278 |
|
|
12 Feb 2025 |
Direct |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Stock Options (right to buy) |
0 |
|
|
09 Apr 2025 |
Direct |